Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Investigation of genetic causes in non-obstructive azoospermic patients
1Department of Urology, Faculty of Medicine, Erzincan Binali Yıldırım University, 24100 Erzincan, Turkey
2Department of Urology, Inonu University Faculty of Medicine, 44050 Malatya, Turkey
3Department of Medical Biology and Genetics, Inonu University Faculty of Medicine, 44050 Malatya, Turkey
DOI: 10.22514/jomh.2025.005 Vol.21,Issue 1,January 2025 pp.51-63
Submitted: 02 July 2024 Accepted: 27 September 2024
Published: 30 January 2025
*Corresponding Author(s): Emre Aykanli E-mail: emre.aykanli@sbu.edu.tr
Background: Male factor infertility is a health problem that affects millions of couples around the world. Male factor infertility is responsible for approximately more than half of all cases of infertility. About 15% of men and 10% of women with infertility may have genetic abnormalities, including chromosomal abnormalities and single gene mutations. In this study, results of genetic analys is of the infertile male patients who underwent testicular sperm extraction (TESE) with the diagnosis of non-obstructive azoospermia were evaluated in order to reveal genetic defects that impair or prevent spermatogenesis in male infertility. Methods: We compared the results of peripheral blood chromosome analysis, molecular karyotyping, male infertility genetic panel, and also testosterone, prolactin, follicular stimulating hormone and luteinizing hormone levels in non-obstructive azoospermic infertile patients aged 26–44 years, and investigated the relationship between these parameters and genetic mutations. Results: As a result of this research, among 26 patients, INSL3 (insulin-like peptide 3) gene mutation, which is considered pathogenic according to the criteria published by the American College of Medical Genetics and Genomics (ACMG) was detected in 1, FSHR (follicle stimulating hormone receptor) gene polymorphism in 17, CFTR (cystic fibrosis transmembrane conductance regulator) mutations in 5, CATSPER1 (cation channel sperm associated 1) and TEX101 (testis expressed 101) in 1, LHCGR (luteinizing hormone/choriogonadotropin receptor) in 1, ZMYND15 (zinc finger mynd-type containing 15) in 1, DNAH5 (dynein axonemal heavy chain 5) in 2, and DNAH11 (dynein axonemal heavy chain 11) changes in 1 patient. In the chromosome analysis, 47XXY Klinefelter syndrome was observed in 6 patients. Conclusions: The results have shown that non-obstructivea zoospermic patients with complaints of infertility may have other genetic abnormalities leading to infertility, despite the results of chromosomal analysis of the peripheral blood samples were within normal reference limits. Investigating these underlying genetic disorders helped us find the cause of infertility in ourpatient population.
Azoospermia; Genetic; Infertility
Bulut Dural,Ilhan Gecit,Emre Aykanli,Cemal Ekici,Fatih Oguz,Ahmet Koc. Investigation of genetic causes in non-obstructive azoospermic patients. Journal of Men's Health. 2025. 21(1);51-63.
[1] Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, et al. European association of urology guidelines on male infertility: the 2012 update. European Urology. 2012; 62: 324–332.
[2] Sengupta P, Dutta S, Tusimin M, Irez T, Krajewska-Kulak E. Sperm counts in Asian men: reviewing the trend of past 50 years. Asian Pacific Journal of Reproduction. 2018; 7: 87–92.
[3] Dutta S, Biswas A, Sengupta P. Obesity, endocrine disruption and male infertility. Asian Pacific Journal of Reproduction. 2019; 8: 195–202.
[4] Rafiee B, Bagher Tabei SM. The effect of N-acetyl cysteine consumption on men with abnormal sperm parameters due to positive history of COVID-19 in the last three months. Archivio Italiano di Urologia e Andrologia. 2021; 93: 465-467.
[5] Stanwell-Smith RE, Hendry WF. The prognosis of male subfertility: a survey of 1025 men referred to a fertility clinic. British Journal of Urology. 1984; 56: 422–428.
[6] Koh E, Sin HS, Fukushima M, Namiki M. Azoospermia factor and male infertility. Reproductive Medicine and Biology. 2010; 9: 129–137.
[7] Abdel-Meguid TA. Predictors of sperm recovery and azoospermia relapse in men with nonobstructive azoospermia after varicocele repair. The Journal of Urology. 2012; 187: 222–226.
[8] Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Human Reproduction Update. 2007; 13: 539–549.
[9] Ratbi I, Legendre M, Niel F, Martin J, Soufir J-C, Izard V, et al. Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Human Reproduction. 2007; 22: 1285–1291.
[10] Metzker ML. Sequencing technologies—the next generation. Nature Reviews Genetics. 2010; 11: 31–46.
[11] Illumina Inc. Next-generation sequencing for beginners. 2023. Available at: https://www.illumina.com/science/technology/next-generation-sequencing/beginners.html (Accessed: 22 March 2023).
[12] Kamieniczna M, Fraczek M, Malcher A, Rozwadowska N, Czernikiewicz A, Jedrzejczak P, et al. Semen quality, hormonal levels, and androgen receptor gene polymorphisms in a population of young male volunteers from two different regions of Poland. Medical Science Monitor. 2015; 21: 2494–2504.
[13] Jiang L, Kong F, Yao L, Zhang F, Wu L, Zhang H, et al. Successful intracytoplasmic sperm injection in a macrozoospermia case with novel compound heterozygous aurora kinase C (AURKC) mutations. Archives of Gynecology and Obstetrics. 2024; 310: 2211–2221.
[14] Soltani M, Rahmati M, Nikravesh MR, Saeedi Nejat S, Jalali M. Inhibition of autophagy in heat-stressed sperm of adult mice: a possible role of Catsper1, 2 channel proteins. Journal of Tropical Medicine. 2023; 2023: 6890815.
[15] Contreras-Marciales ADP, López-Guzmán SF, Benítez-Hess ML, Oviedo N, Hernández-Sánchez J. Characterization of the promoter region of the murine Catsper2 gene. FEBS Open Bio. 2022; 12: 2236–2249.
[16] Campbell K, Zarli M, Schuppe K, Wong R, Rahman F, Ramasamy R. Sexual and reproductive health among men with cystic fibrosis. Urology. 2023; 179: 9–15.
[17] Anbazhagan R, Kavarthapu R, Dufau ML. Chromatoid bodies in the regulation of spermatogenesis: novel role of GRTH. Cells. 2022; 11: 613.
[18] Tan Z, Tian J, Zeng L, Ban W, Zhan Z, Xu J, et al. Identification and expression analysis of dmc1 in Chinese soft-shell turtle (Pelodiscus sinensis) during gametogenesis. Gene. 2025; 932: 148866.
[19] Guo S, Tang D, Chen Y, Yu H, Gu M, Geng H, et al. Association of novel DNAH11 variants with asthenoteratozoospermia lead to male infertility. Human Genomics. 2024; 18: 97.
[20] Li MY, Huang S, Ma LN, Wang AC. Clinical and genetic characteristics of a case of primary ciliary dyskinesia caused by new frameshift mutation of the DNAH5 gene. National Journal of Andrology. 2024; 30: 44–50. (In Chinese)
[21] Alsamri MT, Alabdouli A, Iram D, Alkalbani AM, Almarzooqi AS, Souid AK, et al. A study on the genetics of primary ciliary dyskinesia. Journal of Clinical Medicine. 2021; 10: 5102.
[22] Faja F, Pallotti F, Cargnelutti F, Senofonte G, Carlini T, Lenzi A, et al. Molecular analysis of DPY19L2, PICK1 and SPATA16 in Italian unrelated globozoospermic men. Life. 2021; 11: 641.
[23] Dumasia K, Kumar A, Deshpande S, Balasinor NH. Estrogen, through estrogen receptor 1, regulates histone modifications and chromatin remodeling during spermatogenesis in adult rats. Epigenetics. 2017; 12: 953–963.
[24] Ma Q, Du Y, Luo X, Ye J, Gui Y. Association of ESX1 gene variants with non-obstructive azoospermia in Chinese males. Scientific Reports. 2021; 11: 4587.
[25] Graziani A, Merico M, Grande G, Di Mambro A, Vinanzi C, Rocca MS, et al. A cryptozoospermic infertile male with Y chromosome AZFc microdeletion and low FSH levels due to a simultaneous polymorphism in the FSHB gene: a case report. Human Reproduction. 2024; 39: 504–508.
[26] Petrusová J, Manning J, Kubovčiak J, Kolář M, Filipp D. Two complementary approaches for efficient isolation of Sertoli cells for transcriptomic analysis. Frontiers in Cell and Developmental Biology. 2022; 10: 972017.
[27] Fanis P, Neocleous V, Papapetrou I, Phylactou LA, Skordis N. Gonadotropin-releasing hormone receptor (GnRHR) and hypogonadotropic hypogonadism. International Journal of Molecular Sciences. 2023; 24: 15965.
[28] Dicke AK, Albrethsen J, Hoare BL, Wyrwoll MJ, Busch AS, Fietz D, et al. Bi-allelic variants in INSL3 and RXFP2 cause bilateral cryptorchidism and male infertility. Human Reproduction. 2023; 38: 1412–1423.
[29] Huang Z, Chen F, Xie M, Zhang H, Zhuang Y, Huang C, et al. The I510V mutation in KLHL10 in a patient with oligoasthenoteratozoospermia. Journal of Reproduction and Development. 2021; 67: 313–318.
[30] Bhatnager R, Gaba K, Dang AS. Comprehensive analysis of damage associated SNPs of luteinizing hormone and its receptor: a computational approach. American Journal of Reproductive Immunology. 2024; 91: e13886.
[31] Rocca MS, Msaki A, Ghezzi M, Cosci I, Pilichou K, Celeghin R, et al. Development of a novel next-generation sequencing panel for diagnosis of quantitative spermatogenic impairment. Journal of Assisted Reproduction and Genetics. 2020; 37: 753–762.
[32] Martinez de Lapiscina I, Kouri C, Aurrekoetxea J, Sanchez M, Naamneh Elzenaty R, Sauter KS, et al. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations. PLOS ONE. 2023; 18: e0287515.
[33] Jones C, Meng X, Coward K. Sperm factors and egg activation: Phospholipase C zeta (PLCZ1) and the clinical diagnosis of oocyte activation deficiency. Reproduction. 2022; 164: F53–F66.
[34] Vigolo V, Gautier C, Ertl R, Aurich C, Falomo ME. Protamine 2 and phospholipase C zeta 1 are possible biomarkers for the diagnosis of male subfertility in frozen-thawed stallion semen. Theriogenology. 2024; 215: 343–350.
[35] Aldalaqan S, Dalgliesh C, Luzzi S, Siachisumo C, Reynard LN, Ehrmann I, et al. Cryptic splicing: common pathological mechanisms involved in male infertility and neuronal diseases. Cell Cycle. 2022; 21: 219–227.
[36] Syryn H, Van de Velde J, De Clercq G, Verdin H, Dheedene A, Peelman F, et al. Biallelic RXFP2 variants lead to congenital bilateral cryptorchidism and male infertility, supporting a role of RXFP2 in spermatogenesis. Human Reproduction. 2024; 39: 2353–2363.
[37] Wang HY, Shen YR, Tsai YC, Wu SR, Wang CY, Kuo PL. Proper phosphorylation of septin 12 regulates septin 4 and soluble adenylyl cyclase expression to induce sperm capacitation. Journal of Cellular Physiology. 2023; 238: 597–609.
[38] Biswas S, Mita MA, Afrose S, Hasan MR, Islam MT, Rahman MA, et al. Integrated computational approaches for inhibiting sex hormone-binding globulin in male infertility by screening potent phytochemicals. Life. 2023; 13: 476.
[39] Mao B, Zhang SS, Zhao LT, Huang HR, Ma FD, Shi WJ, et al. The role of SLC26A8 homozygous variants in male infertility and flagellum abnormalities. Asian Journal of Andrology. 2024; 26: 544–546.
[40] Sujit KM, Pallavi S, Singh V, Andrabi SW, Trivedi S, Sankhwar SN, et al. SPATA16 promoter hypermethylation and downregulation in male infertility. Andrologia. 2022; 54: e14548.
[41] Kazi S, Castañeda JM, Savolainen A, Xu Y, Liu N, Qiao H, et al. MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice. The FASEB Journal. 2022; 36: e22479.
[42] Akbari A, Zoha Tabatabaei S, Salehi N, Padidar K, Almadani N, Ali Sadighi Gilani M, et al. Novel STAG3 variant associated with primary ovarian insufficiency and non-obstructive azoospermia in an Iranian consanguineous family. Gene. 2022; 821: 146281.
[43] Pal S, Paladhi P, Dutta S, Mullick RB, Bose G, Ghosh P, et al. Novel mutations reduce expression of meiotic regulators SYCE1 and BOLL in testis of azoospermic men from west Bengal, India. Reproductive Sciences. 2024; 31: 1069–1088.
[44] Gao Y, Zhang D, Wang P, Qu X, Xu J, Yu Y, et al. Acrylamide-induced meiotic arrest of spermatocytes in adolescent mice by triggering excessive DNA strand breaks: potential therapeutic effects of resveratrol. Human & Experimental Toxicology. 2023; 42: 09603271231188293.
[45] Ayhan Ö, Balkan M, Guven A, Hazan R, Atar M, Tok A, et al. Truncating mutations in TAF4B and ZMYND15 causing recessive azoospermia. Journal of Medical Genetics. 2014; 51: 239–244.
[46] Moreno-Irusta A, Dominguez EM, Iqbal K, Zhang X, Wang N, Soares MJ. TAF7L regulates early stages of male germ cell development in the rat. The FASEB Journal. 2024; 38: e23376.
[47] Schiza C, Korbakis D, Jarvi K, Diamandis EP, Drabovich AP. Identification of TEX101-associated proteins through proteomic measurement of human spermatozoa homozygous for the missense variant rs35033974. Molecular & Cellular Proteomics. 2019; 18: 338–351.
[48] Song J, Sha Y, Liu X, Zeng X, Zhao X. Novel mutations of TEX11 are associated with non-obstructive azoospermia. Frontiers in Endocrinology. 2023; 14: 1159723.
[49] Li QY, Zhang YC, Wei C, Liu Z, Song GD, Chen BL, et al. The association between mutations in ubiquitin-specific protease 26 (USP26) and male infertility: a systematic review and meta-analysis. Asian Journal of Andrology. 2022; 24: 422–429.
[50] Cannarella R, Bertelli M, Condorelli RA, Vilaj M, La Vignera S, Jezek D, et al. Analysis of 29 targeted genes for non-obstructive azoospermia: the relationship between genetic testing and testicular histology. World Journal of Men’s Health. 2023; 41: 422–433.
[51] Rohozinski J. Lineage-independent retrotransposition of UTP14 associated with male fertility has occurred multiple times throughout mammalian evolution. Royal Society Open Science. 2017; 4: 171049.
[52] Kherraf ZE, Cazin C, Lestrade F, Muronova J, Coutton C, Arnoult C, et al. From azoospermia to macrozoospermia, a phenotypic continuum due to mutations in the ZMYND15 gene. Asian Journal of Andrology. 2022; 24: 243–247.
[53] Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 2015; 17: 405–423.
[54] Foresta C, Moro E, Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocrine reviews. 2001; 22: 226–239.
[55] Yalcintepe S, Eker D, Gurkan H. The frequency of y chromosome microdeletions and cytogenetic abnormalities in cases with male infertility from Thrace region: single center experience. Journal of Istanbul Faculty of Medicine. 2021; 84: 27–33.
[56] Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Human Genetics. 1991; 87: 81–83.
[57] Dumur V, Gervais R, Rigot JM, Lafitte JJ, Manouvrier S, Biserte J, et al. Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. The Lancet. 1990; 336: 512.
[58] Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, et al. Congenital bilateral absence of vas deferens in the absence of cystic fibrosis. The Lancet. 1994; 344: 1473–1474.
[59] Jalalabadi FN, Cheraghi E, Janatifar R, Momeni HR. The detection of CatSper1 and CatSper3 expression in men with normozoospermia and asthenoteratozoospermia and its association with sperm parameters, fertilization rate, embryo quality. Reproductive Sciences. 2024; 31: 704–713.
[60] Fujihara Y, Okabe M, Ikawa M. GPI-anchored protein complex, LY6K/TEX101, is required for sperm migration into the oviduct and male fertility in mice. Biology of Reproduction. 2014; 90: 60.
[61] Akinloye O, Gromoll J, Callies C, Nieschlag E, Simoni M. Mutation analysis of the X-chromosome linked, testis-specific TAF7L gene in spermatogenic failure. Andrologia. 2007; 39: 190–195.
[62] Ren D, Xia J. Calcium signaling through CatSper channels in mammalian fertilization. Physiology. 2010; 25: 165–175.
[63] Ferlin A, Arredi B, Foresta C. Genetic causes of male infertility. Reproductive Toxicology. 2006; 22: 133–141.
[64] Nef S, Parada LF. Cryptorchidism in mice mutant for Insl3. Nature Genetics. 1999; 22: 295–299.
[65] Lăptoiu AR, Spoială EL, Stanciu GD, Hanganu E, Lupu VV, Ciongradi CI, et al. New insights into the role of INSL-3 in the development of cryptorchidism. Children. 2023; 10: 737.
[66] Ferlin A, Foresta C. The INSL3-LGR8 hormonal system in humans: testicular descent, cryptorchidism and testicular functions. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2005; 5: 421–429.
[67] Foresta C, Garolla A, Bartoloni L, Bettella A, Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. The Journal of Clinical Endocrinology & Metabolism. 2005; 90: 152–156.
[68] Schulz S, Jakubiczka S, Kropf S, Nickel I, Muschke P, Kleinstein J. Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males. Fertility and Sterility. 2006; 85: 135–138.
[69] Kawamura K, Kumagai J, Sudo S, Chun S-Y, Pisarska M, Morita H, et al. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 7323–7328.
[70] Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N, et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. The Journal of Clinical Endocrinology & Metabolism. 2005; 90: 3410–3418.
[71] Adham IM, Agoulnik AI. Insulin-like 3 signalling in testicular descent. International Journal of Andrology. 2004; 27: 257–265.
[72] Rutland J, de Iongh RU. Random ciliary orientation. A cause of respiratory tract disease. The New England Journal of Medicine. 1990; 323: 1681–1684.
[73] Toppari J, Kaleva M, Virtanen HE, Main KM, Skakkebaek NE. Luteinizing hormone in testicular descent. Molecular and Cellular Endocrinology. 2007; 269: 34–37.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)
Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.
Scopus: CiteScore 0.9 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).
Top